India  

"2 Deoxy D Glucose"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials [Video]

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials

Institute of Nuclear Medicine and Allied Sciences-DRDO scientist Dr Sudhir Chandna on drug 2-deoxy-D-glucose (2-DG) while speaking to ANI informed about the observations of the medicine's clinical..

Credit: ANI     Duration: 01:59Published
DCGI approves DRDO's anti-COVID drug helpful in faster recovery [Video]

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients. While speaking to..

Credit: ANI     Duration: 02:44Published
What is 2-DG: New drug approved for Covid emergency use | Oneindia News [Video]

What is 2-DG: New drug approved for Covid emergency use | Oneindia News

The Drugs Controller General of India has granted permission for emergency use of therapeutic application of drug 2-deoxy-D-glucose or 2-DG as adjunct therapy. This was used to treat cancer and showed..

Credit: Oneindia     Duration: 01:24Published

You Might Like


DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D- Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to..
IndiaTimes - Published

Contrary to vow, DRDO drug has steep price tag of Rs 990 a sachet

Contrary to promises that the indigenously developed Covid-19 drug 2-deoxy-D-glucose (2-DG) would be priced affordably to ensure it reaches as many patients as possible, the wonder drug has been priced..
IndiaTimes - Published

DRDO's 2-DG anti-Covid drug to be available by mid-June: Dr Reddy's

Dr Reddy's on Wednesday said that the supply of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation (DRDO) is expected to commence in mid-June. In a..
IndiaTimes - Published

Everything we know about DRDO's COVID medicine

DRDO's newly launched anti-COVID medicine, 2-deoxy-D-glucose is being hailed as an innovative holy grail for COVID patients in India right now, who are currently battling for their lives and scouring..
IndiaTimes - Published

Rajnath Singh releases first batch of DRDO's anti-COVID oral drug 2-deoxy-D-glucose, details inside

Rajnath Singh handed over the anti-COVID drug to his cabinet colleague Harsh Vardhan who handed over it to Delhi AIIMS director.
DNA - Published Also reported by •Zee News

DRDO`s anti-COVID drug: All you need to know about 2-deoxy-D-glucose

Clinical trial results have shown that 2-deoxy-D-glucose helps in faster recovery of hospitalised COVID-19 patients and reduces supplemental oxygen dependence. 
Zee News - Published

2-deoxy-D-glucose: DRDO`s anti-COVID-19 drug is safe, will help patients recover faster, says INMAS scientist

Anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy`s Laboratories (DRL), Hyderabad.
Zee News - Published

All you need to know about DRDO-developed anti-COVID drug, its use, cost, benefits

Anti-COVID drug 2-deoxy-D-glucose (2-DG) comes in powder form in a sachet, which is taken orally by dissolving it in water.
DNA - Published

Potential cancer drug repurposed for Covid-19 by DRDO, Dr Reddy's gets DCGI nod for emergency use

A potential cancer drug repurposed for Covid-19 treatment -- 2-deoxy-D-glucose (2-DG) – has received the Drugs Controller General of India (DCGI) nod for emergency use as adjunct therapy for..
IndiaTimes - Published

DCGI approves anti-Covid drug developed by DRDO for emergency use

The Drugs Controller General of India’s (DCGI) has approved an anti-Coviddrug - 2-deoxy-D-glucose (2-DG) for emergency use. This has been developed by the Institute of Nuclear Medicine and Allied..
IndiaTimes - Published Also reported by •DNAZee News

COVID drug trial completed at KGH

2-Deoxy-D-Glucose administered to nine volunteers; ‘no side effects reported till date’
Hindu - Published

Drug, vaccine trials at AMC designed to eliminate bias

Tests will be conducted for 2-Deoxy-D-Glucose and COVISHIELD
Hindu - Published